Greg P. Forlenza

Pediatric Endocrinology

1775 Aurora Ct Ste A140
Aurora, CO 80045

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 164 publications

A Simple Meal Bolus Strategy is Effective in Adolescents and Young Adults with Type 1 Diabetes on Multiple Automated Insulin Delivery Systems.

A Simple Meal Bolus Strategy is Effective in Adolescents and Young Adults with Type 1 Diabetes on Multiple Automated Insulin Delivery Systems.

Journal: Diabetes technology & therapeutics

Published: July 16, 2026

Settings Associated with Optimal Glycemic Outcomes with the Omnipod® 5 Automated Insulin Delivery System: Evidence from Real-World Users with Type 1 Diabetes.

Settings Associated with Optimal Glycemic Outcomes with the Omnipod® 5 Automated Insulin Delivery System: Evidence from Real-World Users with Type 1 Diabetes.

Journal: Diabetes technology & therapeutics

Published: June 24, 2026

Simplifying meal bolusing with Omnipod 5: real-world outcomes to support simplified user-initiated insulin dosing strategies in managing type 1 or type 2 diabetes.

Simplifying meal bolusing with Omnipod 5: real-world outcomes to support simplified user-initiated insulin dosing strategies in managing type 1 or type 2 diabetes.

Journal: Diabetes research and clinical practice

Published: June 11, 2026

Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe Use.

Adjunctive Treatment with GLP-1 and Dual GLP-1/GIP Receptor Agonists for People with Type 1 Diabetes: Consensus Report and Practical Guidelines for Safe Use.

Journal: Diabetes technology & therapeutics

Published: June 05, 2026

Raising the Bar: High Time in Range During the First Year of Diagnosis of Type 1 Diabetes in Children and Adolescents Using Automated Insulin Delivery with Intense Support.

Raising the Bar: High Time in Range During the First Year of Diagnosis of Type 1 Diabetes in Children and Adolescents Using Automated Insulin Delivery with Intense Support.

Journal: Diabetes technology & therapeutics

Published: May 25, 2026

Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.

Safety and Effectiveness of MiniMed™ 780G Advanced Hybrid Closed-Loop Use with Ultrarapid Insulin Lispro-AABC in Pediatric and Adult Type 1 Diabetes.

Journal: Diabetes technology & therapeutics

Published: April 29, 2026

Quantifying the Effect of Fat and Protein on the Postprandial Glucose Excursion in Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System.

Quantifying the Effect of Fat and Protein on the Postprandial Glucose Excursion in Individuals With Type 1 Diabetes Using an Automated Insulin Delivery System.

Journal: Journal of diabetes science and technology

Published: April 24, 2026

Impact of Early Initiation of Automated Insulin Delivery on Glycemia Two Years from Type 1 Diabetes Diagnosis.

Impact of Early Initiation of Automated Insulin Delivery on Glycemia Two Years from Type 1 Diabetes Diagnosis.

Journal: Hormone research in paediatrics

Published: February 05, 2026

Situational awareness predicts self-management of type I diabetes in adolescents and young adults.

Situational awareness predicts self-management of type I diabetes in adolescents and young adults.

Journal: Health psychology : official journal of the Division of Health Psychology, American Psychological Association

Published: January 20, 2026

Real-World HbA1c Following Initiation of the Omnipod 5 Automated Insulin Delivery System.

Real-World HbA1c Following Initiation of the Omnipod 5 Automated Insulin Delivery System.

Journal: Diabetes technology & therapeutics

Published: November 28, 2025

The Importance of Expanding Medicare Continuous Glucose Monitoring Coverage for High-Risk Hypoglycemia.

The Importance of Expanding Medicare Continuous Glucose Monitoring Coverage for High-Risk Hypoglycemia.

Journal: Diabetes technology & therapeutics

Published: November 21, 2025

Letter: Scientific and Clinical Evaluation of "Dexcom's Fatal Flaws" by Hunterbrook.

Letter: Scientific and Clinical Evaluation of "Dexcom's Fatal Flaws" by Hunterbrook.

Journal: Diabetes technology & therapeutics

Published: November 06, 2025

Showing 1-12 of 164

Last Updated: 09/26/2026